We are live on ! Find out more
DGX icon

Quest Diagnostics

496 hedge funds and large institutions have $8.72B invested in Quest Diagnostics in 2014 Q2 according to their latest regulatory filings, with 54 funds opening new positions, 174 increasing their positions, 176 reducing their positions, and 45 closing their positions.

New
Increased
Maintained
Reduced
Closed

49% more call options, than puts

Call options by funds: $160M | Put options by funds: $108M

20% more first-time investments, than exits

New positions opened: 54 | Existing positions closed: 45

17% more funds holding in top 10

Funds holding in top 10: 67 (+1)

1% more funds holding

Funds holding: 491496 (+5)

2% more capital invested

Capital invested by funds: $8.54B → $8.72B (+$185M)

1% less repeat investments, than reductions

Existing positions increased: 174 | Existing positions reduced: 176

1.91% less ownership

Funds ownership: 104.75%102.83% (-1.9%)

Holders
496
Holders Change
+5
Holders Change %
+1.02%
% of All Funds
14.26%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.2%
New
54
Increased
174
Reduced
176
Closed
45
Calls
$160M
Puts
$108M
Net Calls
+$52.2M
Net Calls Change
+$263M
Name Holding Trade Value Shares
Change
Change in
Stake
AI
26
Analytic Investors
California
$81.8M -$15.3M -260,562 -16%
BIM
27
BlackRock Investment Management
Delaware
$81.2M +$22.3M +380,838 +38%
OSAM
28
O'Shaughnessy Asset Management
Connecticut
$77.8M +$34.8M +594,682 +81%
Wells Fargo
29
Wells Fargo
California
$76.6M +$3.51M +59,995 +5%
T
30
TOBAM
France
$70.7M +$29.9M +510,949 +74%
LSV Asset Management
31
LSV Asset Management
Illinois
$66.2M +$49.1M +839,121 +291%
First Trust Advisors
32
First Trust Advisors
Illinois
$65.4M +$2.44M +41,687 +4%
CCM
33
Camber Capital Management
Massachusetts
$64.6M
Geode Capital Management
34
Geode Capital Management
Massachusetts
$62.2M -$666K -11,366 -1%
NTC
35
North Tide Capital
Massachusetts
$58.7M
Balyasny Asset Management
36
Balyasny Asset Management
Illinois
$54.6M +$25.3M +432,747 +87%
AAM
37
Aberdeen Asset Management
United Kingdom
$53M -$386M -6,594,128 -88%
Goldman Sachs
38
Goldman Sachs
New York
$46.5M +$7.07M +120,713 +18%
SCM
39
Sarissa Capital Management
Connecticut
$45.5M
Deutsche Bank
40
Deutsche Bank
Germany
$44.7M -$23.1M -394,241 -34%
UBS AM
41
UBS AM
Illinois
$43.5M +$3.04M +51,994 +8%
ARC
42
Absolute Return Capital
Massachusetts
$42.5M -$12.4M -211,424 -23%
ACM
43
Addison Clark Management
Connecticut
$42.4M +$42.3M +722,440 New
Legal & General Group
44
Legal & General Group
United Kingdom
$41.4M +$1.62M +27,727 +4%
MAA
45
Managed Account Advisors
New Jersey
$40.8M +$5.35M +91,285 +15%
IG
46
ING Group
Netherlands
$37.7M -$4.77M -81,400 -11%
Canada Life
47
Canada Life
Manitoba, Canada
$37.4M +$4.2M +71,767 +13%
GC
48
Guggenheim Capital
Illinois
$34.8M +$8.4M +143,481 +32%
Acadian Asset Management
49
Acadian Asset Management
Massachusetts
$34.3M +$10.9M +186,549 +47%
SI
50
Sentry Investments
Ontario, Canada
$33M +$6.15M +105,000 +23%

DGX Hedge Fund Activity: Q2 2014 in Review

496 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Quest Diagnostics (DGX) for Q2 2014, worth a combined $8.72B — up 2.2% from $8.54B a quarter earlier.

Buyers outnumbered sellers: 54 funds opened new DGX positions and 45 closed out — a net gain of 9 holders — while 174 added to existing stakes and 176 trimmed.

The largest buyer was Bank of America, adding an estimated $341M. The largest seller was Aberdeen Asset Management, cutting an estimated $386M.

  • 496 institutional investors held Quest Diagnostics (DGX) as of Q2 2014, up from 491 in Q1 2014.
  • Funds reported $8.72B of Quest Diagnostics stock for Q2 2014, up 2.2% quarter-over-quarter.
  • 54 funds opened new Quest Diagnostics positions in Q2 2014 and 45 closed out, a net change of +9 holders.
  • The largest Quest Diagnostics buyer in Q2 2014 was Bank of America, an estimated $341M added.
  • The largest Quest Diagnostics seller in Q2 2014 was Aberdeen Asset Management, an estimated $386M sold.

Based on aggregated 13F filings for Q2 2014.